Wei P, Li Ch, Qiang L, He J, Li Z, Hua H. Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren’s syndrome. Med Oral Patol Oral Cir Bucal. 2015 Mar 1;20 (2):e156-60. 

 

 

doi:10.4317/medoral.20199

http://dx.doi.org/doi:10.4317/medoral.20199

 

 

1. Fox RI. Sjögren's syndrome. Lancet. 2005;366:321-31.
http://dx.doi.org/10.1016/S0140-6736(05)66990-5

 

2. Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, et al. Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan. Mod Rheumatol. 2014;24:464-70.
http://dx.doi.org/10.3109/14397595.2013.843765

 

3. Wakamatsu E, Nakamura Y, Matsumoto I, Goto D, Ito S, Tsutsumi A, et al. DNA microarray analysis of labial salivary glands of patients with Sjogren's syndrome. Ann Rheum Dis. 2007;66:844-5.
http://dx.doi.org/10.1136/ard.2006.063370

 

4. Kruszka P, O'Brian RJ. Diagnosis and management of Sjogren syndrome. Am Fam Physician. 2009;79:465-70.

 

5. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004;164:1275-84.
http://dx.doi.org/10.1001/archinte.164.12.1275

 

6. Anderson JR, Gray KG, Beck JS, Kinnear WF. Precipitating autoantibodies in Sjogren's disease. Lancet. 1961;2:456-60.
http://dx.doi.org/10.1016/S0140-6736(61)92430-8

 

7. Menéndez A, Gómez J, Escanlar E, Caminal-Montero L, Mozo L. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection. Autoimmunity. 2013;46:32-9.
http://dx.doi.org/10.3109/08916934.2012.732131

 

8. Barakat S, Meyer O, Torterotot F, Youinou P, Briand JP, Kahn MF, et al. IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein. Clin Exp Immunol. 1992;89:38-45.
http://dx.doi.org/10.1111/j.1365-2249.1992.tb06874.x

 

9. F. Franceschini I. Cavazzana. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity. 2005;38:55-63.
http://dx.doi.org/10.1080/08916930400022954

 

10. Alexander EL, Arnett FC, Provost TT, Stevens MB. Sjogren's syndrome: association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med. 1983;98:155-9.
http://dx.doi.org/10.7326/0003-4819-98-2-155

 

11. Moody M, Zipp M, Alhashimi I. Salivary anti-spectrin autoantibodies in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:322-7.
http://dx.doi.org/10.1067/moe.2001.112498

 

12. Baldini C, Gallo A, Perez P, Mosca M, Alevizos I, Bombardieri S. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome. Clin Exp Rheumatol. 2012;30:785-90.

 

13. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002; 61:554-58.
http://dx.doi.org/10.1136/ard.61.6.554

 

14. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
http://dx.doi.org/10.1002/art.1780400928

 

15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classifi cation of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
http://dx.doi.org/10.1002/art.1780310302

 

16. Ben-Chetrit E, Fischel R, Rubinow A. Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome. Clin Rheumatol. 1993;12:471-4.
http://dx.doi.org/10.1007/BF02231773

 

17. Busamia B, Gonzales-Moles MA, Mazzeo M, Linares J, Demarchi M, Gobbi C, et al. Assessing the determination of salivary electrolytes and anti-Ro and anti-La antibodies for the diagnosis of Sjögren's syndrome (SS). Med Oral Patol Oral Cir Bucal. 2010;15:e437-40.
http://dx.doi.org/10.4317/medoral.15.e437

 

18. Qin Q, Wang H, Wang HZ, Huang YL, Li H, Zhang WW, et al. Diagnostic accuracy of anti-alpha-fodrin antibodies for primary Sjögren's syndrome. Mod Rheumatol. 2014;24:793-7.
http://dx.doi.org/10.3109/14397595.2013.865823

 

19. He J, Qiang L, Ding Y, Wei P, Li YN, Hua H, et al. The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjögren's syndrome. Clin Exp Rheumatol. 2012;30:322-6.

 

20. Sreebny LM, Zhu WX. The use of whole saliva in the differential diagnosis of Sjögren's syndrome. Adv Dent Res. 1996;10:17-24.
http://dx.doi.org/10.1177/08959374960100010201

 

21. Hammi AR, Al-Hashimi IH, Nunn ME, Zipp M. Assessment of SS-A and SS-B in parotid saliva of patients with Sjogren's syndrome. J Oral Pathol Med. 2005;34:198-203.
http://dx.doi.org/10.1111/j.1600-0714.2004.00301.x

 

22. Atkinson JC, Royce LS, Wellner R, Pillemer SR, Bermudez D, Fox PC. Anti-salivary antibodies in primary Sjögren's syndrome. J Oral Pathol Med. 1995;24:206-12.
http://dx.doi.org/10.1111/j.1600-0714.1995.tb01168.x

 

23. Takada K, Suzuki K, Okada M, Nakashima M, Ohsuzu F. Salivary production rates fall with age in subjects having anti-centromere, anti-Ro, and/or anti-La antibodies. Scand J Rheumatol. 2006;35:23-8.
http://dx.doi.org/10.1080/03009740500311788